{"entity":{"id":"da-trial-biib080","kind":"trial","name":"Diranersen / BIIB080 Phase 2","aka":[],"tldr":"Phase 2 study of BIIB080, an investigational tau-lowering antisense medicine.","summary":"Intrathecal ASO programme. Safety and symptom outcomes are still being established. Trial-only access.","status":"recruiting","asOf":"2026-09-21","links":[{"label":"ClinicalTrials.gov NCT05399888","url":"https://clinicaltrials.gov/study/NCT05399888"}],"tags":["dementia-atlas"],"related":[],"cancers":["alzheimers-disease","mild-cognitive-impairment"],"sections":[],"technologies":[],"targets":[],"drugs":["da-biib080"],"companies":["da-biogen"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05399888","phase":"2","setting":"MCI due to AD or mild AD dementia","sponsor":"Biogen","outcomes":[]},"route":"/trials/da-trial-biib080/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"},{"id":"mild-cognitive-impairment","kind":"cancer","name":"Mild cognitive impairment","route":"/diagnoses/mild-cognitive-impairment/"}],"drug":[{"id":"da-biib080","kind":"drug","name":"Diranersen (BIIB080)","route":"/drugs/da-biib080/"}],"company":[{"id":"da-biogen","kind":"company","name":"Biogen","route":"/companies/da-biogen/"}]}}